Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05190341 · ClinicalTrials.gov registry record · Phase 4
Ibuprofen Versus Ketorolac for Pain Relief During Hysterosalpingogram
A Phase 4 study, sponsored by Madigan Army Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT05190341 is a Phase 4 study that was terminated before completion, run by Madigan Army Medical Center. The registered enrollment target is 12 participants.
The verdict
NCT05190341, a Phase 4 study, was terminated before completion, sponsored by Madigan Army Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
Hysterosalpingogram (HSG) testing is a vital part of the workup for infertility patients. It is often noted to be biggest pain that patients undergo during the workup. Several studies have attempted to find a therapy that reduces pain, with non-steroidal anti-inflammatory drugs such as oral ibuprofen the current mainstay. Our study attempts to determine which of the following NSAIDS is best at reducing pain associated with the HSG procedure: oral ibuprofen versus oral ketorolac .
Interventions
- DRUG Ibuprofen 800 mg oral
- DRUG Ketorolac 30mg oral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-03-24 |
| Est. Completion | 2024-10-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05190341
The ClinicalTrials.gov registry entry for NCT05190341 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Madigan Army Medical Center, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen 800 mg oral is the first listed.
NCT05190341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05190341 about?
NCT05190341 is a clinical study titled "Ibuprofen Versus Ketorolac for Pain Relief During Hysterosalpingogram". Hysterosalpingogram (HSG) testing is a vital part of the workup for infertility patients. It is often noted to be biggest pain that patients undergo during the workup. Several studies have attempted to find a therapy that reduces pain, with non-steroidal anti-inflammatory drugs such as oral ibuprofe...
What is the current status of trial NCT05190341?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2022-03-24. Estimated completion is 2024-10-10.
What interventions are being tested in trial NCT05190341?
The interventions under investigation include: Ibuprofen 800 mg oral (DRUG), Ketorolac 30mg oral (DRUG).
Who is sponsoring clinical trial NCT05190341?
This trial is sponsored by Madigan Army Medical Center, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.